arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

NU SKIN ENTERPRISES, INC.

NUS
$4.63 ▼ -0.24 (-4.83%) at close
Healthcare ·Wholesale-Drugs, Proprietaries & Druggists' Sundries ·USWholesale-Drugs, Proprietaries & Druggists' Sundries
71 Visible periods
34 Metrics
Peer-ranked Benchmarks
Price Chart
63
Health
Fair
Bullish
auto_awesome

Analytical Summary

NU SKIN ENTERPRISES, INC. shows strong fundamentals with top-quartile Return on Common Equity (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $225.0M
Dividend Yield —
Revenue Growth -17.1% ↘
Op. Margin -18.5% ↘
ROIC -31.9% ↘
FCF / Share $0.10 ↗
Trailing P/E —
Price / Book 0.4x
FCF Yield 2.2%
Debt / Equity 0.36
info Valuation on last close. End-of-day price, Sep 23, 2026.

71-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$320.11M
↓ -17.1% —
Net Income Profit after all expenses
$-249.80M
↓ -13705.6% —
Operating Margin Operating profit as % of sales
-18.5%
↓ -1575.7% 41th
FCF / Share Free cash flow per share
$0.10
↑ +128.1% —
Long-Term Debt Long-term obligations
$193.66M
↓ -4.9% —
trending_up

Bullish Indicators

  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability ↑
48
Returns ↑
86
Financial Health ↓
69
Cash Quality ↓
32

Dividend History

Dividend / share · sourced from SEC filings
$0.34 Latest / share

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 19 years · 71 quarters